Tessera Therapeutics, a genetic medicine company, is laying off 90 employees as it refocuses on a new partnership.
1 minute to read
Tessera Therapeutics, a high-profile Somerville biotech developing next-generation gene-writing technology, is cutting about 35% of its workforce as it shifts its focus to a new partnership with Regeneron…